AZTR
Price
$0.75
Change
+$0.06 (+8.70%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
4.08M
35 days until earnings call
Intraday Buy/Sell Signals
SNBIF
Price
$16.45
Change
+$2.17 (+15.20%)
Updated
Aug 6 closing price
Capitalization
1.82B
Intraday Buy/Sell Signals
Interact to see
Advertisement

AZTR vs SNBIF

Header iconAZTR vs SNBIF Comparison
Open Charts AZTR vs SNBIFBanner chart's image
Azitra
Price$0.75
Change+$0.06 (+8.70%)
Volume$900
Capitalization4.08M
Sanbio
Price$16.45
Change+$2.17 (+15.20%)
Volume$500
Capitalization1.82B
AZTR vs SNBIF Comparison Chart in %
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTR vs. SNBIF commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTR is a StrongBuy and SNBIF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (AZTR: $0.69 vs. SNBIF: $16.45)
Brand notoriety: AZTR and SNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AZTR: 4% vs. SNBIF: 100%
Market capitalization -- AZTR: $3.75M vs. SNBIF: $1.82B
AZTR [@Biotechnology] is valued at $3.75M. SNBIF’s [@Biotechnology] market capitalization is $1.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTR’s FA Score shows that 1 FA rating(s) are green whileSNBIF’s FA Score has 0 green FA rating(s).

  • AZTR’s FA Score: 1 green, 4 red.
  • SNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, AZTR is a better buy in the long-term than SNBIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTR’s TA Score shows that 4 TA indicator(s) are bullish while SNBIF’s TA Score has 1 bullish TA indicator(s).

  • AZTR’s TA Score: 4 bullish, 3 bearish.
  • SNBIF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, AZTR is a better buy in the short-term than SNBIF.

Price Growth

AZTR (@Biotechnology) experienced а -11.42% price change this week, while SNBIF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.86%. For the same industry, the average monthly price growth was +14.21%, and the average quarterly price growth was +268.76%.

Reported Earning Dates

AZTR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNBIF($1.82B) has a higher market cap than AZTR($4.08M). SNBIF YTD gains are higher at: 253.763 vs. AZTR (-73.654). AZTR has higher annual earnings (EBITDA): -8.89M vs. SNBIF (-2.99B). AZTR (0) and SNBIF (0) have equivalent revenues.
AZTRSNBIFAZTR / SNBIF
Capitalization4.08M1.82B0%
EBITDA-8.89M-2.99B0%
Gain YTD-73.654253.763-29%
P/E Ratio0.03N/A-
Revenue00-
Total Cash1.05MN/A-
Total Debt578KN/A-
FUNDAMENTALS RATINGS
SNBIF: Fundamental Ratings
SNBIF
OUTLOOK RATING
1..100
47
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AZTRSNBIF
RSI
ODDS (%)
Bullish Trend 7 days ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 7 days ago
65%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
13%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
9%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 16 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DYN15.471.44
+10.26%
Dyne Therapeutics
FRGT1.280.01
+0.79%
Freight Technologies Inc
WTRG39.940.16
+0.41%
Essential Utilities
SITC8.61-0.03
-0.35%
SITE Centers Corp
XBIT2.50-0.06
-2.34%
XBiotech

AZTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTR has been closely correlated with RIGL. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if AZTR jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTR
1D Price
Change %
AZTR100%
+7.64%
RIGL - AZTR
84%
Closely correlated
+2.09%
DARE - AZTR
78%
Closely correlated
-2.74%
IMRN - AZTR
72%
Closely correlated
-1.44%
PHIO - AZTR
49%
Loosely correlated
+1.83%
SNBIF - AZTR
46%
Loosely correlated
N/A
More

SNBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNBIF has been loosely correlated with AZTR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNBIF jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNBIF
1D Price
Change %
SNBIF100%
N/A
AZTR - SNBIF
46%
Loosely correlated
+0.52%
ANTX - SNBIF
33%
Loosely correlated
N/A
SONN - SNBIF
28%
Poorly correlated
-0.91%
RZLT - SNBIF
5%
Poorly correlated
-2.42%
SPHRY - SNBIF
3%
Poorly correlated
N/A
More